Fig. 3. Short-term (3 months) treatment responses of the 50 achalasia patients. Type II achalasia shows good treatment outcomes in pneumatic dilatation (PD; 6/7, 85.7%) and laparoscopic Heller's myotomy (LHM; 3/4, 75.0%) in comparison with type I achalasia (5/7, 71.4% in PD and 2/4, 50.0% in LHM). All type III achalasia patients responded to calcium channel blocker (CCB) (A). Long-term (≥ 5 years) treatment responses and clinical follow-up of the 13 achalasia patients. Of the 13 patients, 2 patients who showed good response on PD or LHM relapsed after 5 years and the symptoms of 3 achalasia patients who showed poor response to initial PD or LHM persisted which needed further treatment. *Two achalasia patients who were treated with CCB were followed up with high-resolution manometry (B). Others include proton pump inhibitor, motility drug or antacid. Stable means Eckardt symptom score 3 or less. Relapse means Eckardt symptom more than 3. Good, good response; Poor, poor response.
© J Neurogastroenterol Motil
